» Articles » PMID: 23533956

Clinical Trials in Cardiac Arrest and Subarachnoid Hemorrhage: Lessons from the Past and Ideas for the Future

Overview
Publisher Wiley
Date 2013 Mar 28
PMID 23533956
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction. Elevated intracranial pressure that occurs at the time of cerebral aneurysm rupture can lead to inadequate cerebral blood flow, which may mimic the brain injury cascade that occurs after cardiac arrest. Insights from clinical trials in cardiac arrest may provide direction for future early brain injury research after subarachnoid hemorrhage (SAH). Methods. A search of PubMed from 1980 to 2012 and clinicaltrials.gov was conducted to identify published and ongoing randomized clinical trials in aneurysmal SAH and cardiac arrest patients. Only English, adult, human studies with primary or secondary mortality or neurological outcomes were included. Results. A total of 142 trials (82 SAH, 60 cardiac arrest) met the review criteria (103 published, 39 ongoing). The majority of both published and ongoing SAH trials focus on delayed secondary insults after SAH (70%), while 100% of cardiac arrest trials tested interventions within the first few hours of ictus. No SAH trials addressing treatment of early brain injury were identified. Twenty-nine percent of SAH and 13% of cardiac arrest trials showed outcome benefit, though there is no overlap mechanistically. Conclusions. Clinical trials in SAH assessing acute brain injury are warranted and successful interventions identified by the cardiac arrest literature may be reasonable targets of the study.

Citing Articles

Multimodal Neuromonitoring and Neurocritical Care in Swine to Enhance Translational Relevance in Brain Trauma Research.

ODonnell J, Browne K, Kvint S, Makaron L, Grovola M, Karandikar S Biomedicines. 2023; 11(5).

PMID: 37239007 PMC: 10216032. DOI: 10.3390/biomedicines11051336.


The Role of Platelet Activation and Inflammation in Early Brain Injury Following Subarachnoid Hemorrhage.

Frontera J, Provencio J, Sehba F, McIntyre T, Nowacki A, Gordon E Neurocrit Care. 2016; 26(1):48-57.

PMID: 27430874 PMC: 6354928. DOI: 10.1007/s12028-016-0292-4.


Role of unphosphorylated transcription factor STAT3 in late cerebral ischemia after subarachnoid hemorrhage.

Samraj A, Muller A, Grell A, Edvinsson L J Cereb Blood Flow Metab. 2014; 34(5):759-63.

PMID: 24517975 PMC: 4013756. DOI: 10.1038/jcbfm.2014.15.

References
1.
Patrick W, Freedman J, McEwen T, Light R, Ludwig L, Roberts D . A randomized, double-blind comparison of methoxamine and epinephrine in human cardiopulmonary arrest. Am J Respir Crit Care Med. 1995; 152(2):519-23. DOI: 10.1164/ajrccm.152.2.7633701. View

2.
Gueugniaud P, Mols P, Goldstein P, Pham E, Dubien P, Deweerdt C . A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. European Epinephrine Study Group. N Engl J Med. 1998; 339(22):1595-601. DOI: 10.1056/NEJM199811263392204. View

3.
Loch Macdonald R, Higashida R, Keller E, Mayer S, Molyneux A, Raabe A . Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke. 2012; 43(6):1463-9. DOI: 10.1161/STROKEAHA.111.648980. View

4.
Lynch J, Wang H, McGirt M, Floyd J, Friedman A, Coon A . Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke. 2005; 36(9):2024-6. DOI: 10.1161/01.STR.0000177879.11607.10. View

5.
Walter P, Neil-Dwyer G, Cruickshank J . Beneficial effects of adrenergic blockade in patients with subarachnoid haemorrhage. Br Med J (Clin Res Ed). 1982; 284(6330):1661-4. PMC: 1498581. DOI: 10.1136/bmj.284.6330.1661. View